CIK: 1555276 - Address: C/o Avista Capital Holdings, L.P., 65 E. 55Th Street, 18Th Floor, New York, NY 10022
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1150-2358166
S%wins8080604060053

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/26/19 17:41
11/25/19
OPTNOptinose, Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Partners II Gp, LLCNYTS-11,4569.170-1,250-61808I
6/13/18 16:50
6/11/18
OPTNOptinose, Inc.DEHealthDrugPharmaceutical PreparationsAvista Capital Partners II Gp, LLCNYTS-60,13120.920-2,875-77879I
8/5/16 15:25
8/4/16
INCRInc Research Holdings, Inc.DEHealthBiolabCommercial Physical & BiologiAvista Capital Partners II Gp, LLCNCTS-107,43842.0633-2,554-384,120I-101621497520-2120
5/9/16 16:22
5/6/16
INCRInc Research Holdings, Inc.DEHealthBiolabCommercial Physical & BiologiAvista Capital Partners II Gp, LLCNCTS-184,40845.1233-4,087-386,674I481209-11-910-3-30-3
12/8/15 17:14
12/7/15
INCRInc Research Holdings, Inc.DEHealthBiolabCommercial Physical & BiologiAvista Capital Partners II Gp, LLCNCTS-206,90745.0025-4,598-3010,761I9022413-1-83-100-10-413
8/18/15 17:01
8/17/15
INCRInc Research Holdings, Inc.DEHealthBiolabCommercial Physical & BiologiAvista Capital Partners II Gp, LLCNCTS-177,28344.0025-4,029-2115,359I773496-8-1-1-1051-122
5/15/15 17:15
5/14/15
INCRInc Research Holdings, Inc.DEHealthBiolabCommercial Physical & BiologiAvista Capital Partners II Gp, LLCNCTS-195,88129.6815-6,600-2519,388I5935410-440114333833

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact